Partner Headlines - CVS

  1. Ray Dalio Invests in Nearly 4 Dozen New Stakes

    GuruFocus
  2. Jim Cramer Advises Viewers On Carnival Corp, Chicago Bridge & ...

    Benzinga
  3. Cisco PT Raised; SolarCity Upgraded; Disney, CVS PTs Cut

    IBD
  4. CVS Meets, Beats Q4 Views Amid Challenges; Stock Rises

    IBD
  5. Stocks Buffeted Between Short-Term Oil Gains, Global Economic ...

    Benzinga
  6. Polcari: Markets In Turmoil, Euro Bank Stocks Take A Hit

    IBD
  7. 7 Stocks You Should Be Watching Today

    Benzinga
  8. Will Mild Flu Season Knock CVS Health’s Q4 Earnings?

    IBD
  9. Stock Mutual Funds Could See Some Recovery By Midyear

    IBD
  10. Bill Gates, Apple Chair, Nike CEO Lead Week’s Insider Trades

    IBD
  11. Mario Gabelli Comments on CVS Health Corp

    GuruFocus
  12. Apple Supplier Qualcomm, JD Upgraded; Baidu Downgraded

    IBD
  13. Stephen Weiss Sees Value Buys After The Correction

    Benzinga
  14. Steven Romick Sells Microsoft, Walgreens, CVS

    GuruFocus
  15. Amazon.com Turned Its Back On YouTube Video Ads

    IBD
  16. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD
  17. Walgreens-Rite Aid Deal, Generics To Dent McKesson

    IBD
  18. Walgreens Q1 Mixed; Rite Aid Buy Going As Planned

    IBD
  19. Walgreens Sales Expected To Slow Slightly In Q1 2016

    IBD
  20. Rite Aid Sales Slip; WellCare Shifts PBM Work

    IBD
  21. Louis Moore Bacon's Largest 3rd Quarter Trades

    GuruFocus
  22. Evercore Partners Lands Advisory Fees On Big Deals

    IBD
  23. Express Scripts Gets Mixed Reviews After '16 Guidance

    IBD
  24. Fitbit, Under Armour Are Buys; Boeing Downgraded

    IBD
  25. Benzinga's Top Initiations

    Benzinga
  26. First Pacific Advisors Slashes Stake in CVS Health

    GuruFocus
  27. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD
  28. Avon To Sell 80% Of N. America Unit Amid Sales Woes

    IBD
  29. Rite Aid Q3 Hit By Envision Rx Buy, Reaffirms Outlook

    IBD
  30. CVS hikes guidance, dividend

    IBD
  31. CVS Health Hikes Dividend 21%; Target Deal Closed

    IBD
  32. Valeant To Cut Drug Prices In Team-Up With Walgreens

    IBD
  33. Health Care Stocks Play Prominent Roles in Steven Romick's Transactions

    GuruFocus
  34. John Rogers Sells Position in CVS

    GuruFocus
  35. Taking a Look at Barron's 10 Favorite Stocks for 2016

    GuruFocus
  36. Top Performing Industries For December 7, 2015

    Benzinga
  37. LinkedIn, Palo Alto, Regeneron Profit Estimates Rising

    IBD
  38. UNH CEO: Early ObamaCare Entry A 'Bad Decision'

    IBD
  39. CVS Makes Amgen New BFF

    IBD
  40. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD
  41. CVS Health Announces Formulary and Therapy Strategy for PCSK9 ...

    Benzinga
  42. Drugstore Stocks Fall After UNH's ObamaCare Warning

    IBD
  43. Horizon Slams Express Scripts Amid Pharmacy Dispute

    IBD
  44. Horizon Pharma Soars On Big Q3 Beat, Guidance Raise

    IBD
  45. How the Walgreens-Rite Aid Deal Stacks Up Against Paulson's Merger ...

    GuruFocus
  46. Can Apple Pay Get A Lift From Walgreens Rewards?

    IBD
  47. The Biggest Misunderstanding About Shopify

    FoxBusiness
  48. Walgreens Buys Rite Aid to Avoid Loose Market

    GuruFocus
  49. M&A Hits $4 Trillion At Fastest Pace on Record

    FoxBusiness
  50. Valeant Dumps Philidor, Falls

    IBD
  51. CVS Sneezes, Street Gets Flu

    IBD
  52. No Tricks, Just Treats for Wall Street in October

    FoxBusiness
  53. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  54. Mid-Afternoon Market Update: Aaron's Slides On Earnings Miss; ...

    Benzinga
  55. CVS Health Corp Sharply Lower Following Q3 Report

    Benzinga
  56. How Rite Aid Deal Will Change Walgreens

    GuruFocus
  57. CVS Guides 2016 Low As Walgreens, Rite Aid To Merge

    IBD
  58. Mid-Day Market Update: Cray Surges On Upbeat Results; DigitalGlobe ...

    Benzinga
  59. Valeant Dumps Philidor As Stock Keeps Hemorrhaging

    IBD
  60. Worst Performing Industries For October 30, 2015

    Benzinga
  61. Stocks Off To Wobbly Start; Priceline, LinkedIn Up

    IBD
  62. Herbalife Jabs Bill Ackman Over Troubled Valeant

    FoxBusiness
  63. Mid-Morning Market Update: Markets Mostly Flat; CVS Health Issues ...

    Benzinga
  64. Morning Market Losers

    Benzinga
  65. Weak Data, Rising Stock Futures; Baidu, First Solar, MaxLinear ...

    IBD
  66. Benzinga's Top #PreMarket Losers

    Benzinga
  67. US Stock Futures Edge Higher Ahead Economic Data

    Benzinga
  68. CVS Health Posts In-Line Q3 Earnings, But Issues Weak Profit ...

    Benzinga
  69. 10 Must Watch Stocks for Today

    Benzinga
  70. Earnings Scheduled For October 30, 2015

    Benzinga
  71. Valeant Falls On CVS, Express

    IBD
  72. Valeant Hit As CVS, Express Scripts Dump Philidor

    IBD
  73. Stocks Dip In Light Trade; LinkedIn Soars After Hours

    IBD
  74. Cardinal Health: Dividend Aristocrats Part 17 of 52

    GuruFocus
  75. Walgreens Reverses On Weak Outlook After Rite Aid Buy

    IBD
  76. Walgreens To Buy Rite Aid

    IBD
  77. Walgreens Will Buy Rival Rite Aid In $17.2 Bil Deal

    IBD
  78. Steven Romick Sells CVS, Buys United Technologies

    GuruFocus
  79. Rite Aid Spikes 39% On Reported Walgreens Buy Talks

    IBD
  80. Wall St. Expects CVS Profit Up 12%, Walgreens 9.5%

    IBD
  81. Ulta Beauty Lures Teen Shoppers

    IBD
  82. Target Corp.: Dividend Aristocrats Part 13 of 52

    GuruFocus
  83. Horizon Pharma Counters Depomed Hit On Drug Pricing

    IBD
  84. 4 Ways Ulta Plans To Keep Earning Pretty Profits

    IBD
  85. Ulta, Sephora Steal Teen Girls' Hearts From CVS

    IBD
  86. Sucampo Aims To Be More Than Just A One-Drug Wonder

    IBD
  87. Running On Fumes? Gas Prices, Vaping Boost Tobacco Firms

    IBD
  88. Volkswagen's Mess is a Boon to Rival Stocks

    FoxBusiness
  89. Fast Money Picks For September 22

    Benzinga
  90. Broadcom, Pall Corp. Among Paul Tudor Jones' Recent Buys

    GuruFocus
  91. Goldman Sachs' Stock Picks if Rates Rise

    FoxBusiness
  92. CVS Health Announces New Clinical Affiliations with St. Luke's ...

    Benzinga
  93. A Look at Steven Cohen's Investment in Ironwood Pharmaceuticals

    GuruFocus
  94. The Alfred E. Neuman Stock Market

    Benzinga
  95. Black Monday, Part Deux: Dow Falls 1,000 Points, Several Blue ...

    Benzinga
  96. Three Reasons to Own CVS

    GuruFocus
  97. Walmart Can Overcome Near-Term Challenges

    GuruFocus
  98. Sucampo hits high on EPS

    IBD
  99. Sucampo Stock Hits High On EPS, But CVS Nixes Drug

    IBD
  100. The Cleanup in the Checkout Aisle

    FoxBusiness
Trading Center